Cargando…
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Autores principales: | Nong, Jingying, Gong, Yuhua, Guan, Yanfang, Yi, Xin, Yi, Yuting, Chang, Lianpeng, Yang, Ling, Lv, Jialin, Guo, Zhirong, Jia, Hongyan, Chu, Yuxing, Liu, Tao, Chen, Ming, Byers, Lauren, Roarty, Emily, Lam, Vincent K., Papadimitrakopoulou, Vassiliki A., Wistuba, Ignacio, Heymach, John V., Glisson, Bonnie, Liao, Zhongxing, Lee, J. Jack, Futreal, P. Andrew, Zhang, Shucai, Xia, Xuefeng, Zhang, Jianjun, Wang, Jinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351618/ https://www.ncbi.nlm.nih.gov/pubmed/30696827 http://dx.doi.org/10.1038/s41467-019-08570-x |
Ejemplares similares
-
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
por: Nong, Jingying, et al.
Publicado: (2018) -
Crizotinib versus platinum‐based double‐agent chemotherapy as the first line treatment in advanced anaplastic lymphoma kinase‐positive lung adenocarcinoma
por: Zhang, Quan, et al.
Publicado: (2015) -
HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib
por: Zhang, Xinyong, et al.
Publicado: (2020) -
Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
por: Zhang, Qi, et al.
Publicado: (2019) -
Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma
por: Qiao, Xiaojuan, et al.
Publicado: (2015)